(Q31112947)

28 June 2017

Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates (English)

1 reference

28 June 2017

1 reference

Andrianov AM

1

1 reference

PubMed ID

17508782

28 June 2017

Veresov VG

series ordinal

2

1 reference

PubMed ID

17508782

28 June 2017

language of work or name

1 reference

1 June 2007

1 reference

Journal of Biomolecular Structure and Dynamics

28 June 2017

1 reference

28 June 2017

24

1 reference

28 June 2017

6

1 reference

28 June 2017

597-608

1 reference

28 June 2017

V3: HIV's switch-hitter

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

HIV-1 gp120 V3 loop for structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

A structure-based approach to a synthetic vaccine for HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Different immune response of mice immunized with conjugates containing multiple copies of either consensus or mixotope versions of the V3 loop peptide from human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Conformational model for the consensus V3 loop of the envelope protein gp120 of HIV-1 in a 20% trifluoroethanol/water solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Solid-state NMR yields structural constraints on the V3 loop from HIV-1 Gp120 bound to the 447-52D antibody Fv fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

The HF-SCF energy of HIV-1 MNgp120 V3 hairpin loop conformers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Global and local structural properties of the principal neutralizing determinant of the HIV-1 envelope protein gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Structure and polymorphism of the principal neutralization site of Thailand HIV-1 isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

3D structure model of the principal neutralizing epitope of Minnesota HIV-1 isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Dual spatial folds and different local structures of the HIV-1 immunogenic crown in various virus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Conformational preferences of the HIV-1 principal neutralizing determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Determination of structurally conservative amino acids of the HIV-1 protein gp120 V3 loop as promising targets for drug design by protein engineering approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Derivation of locally accurate spatial protein structure from NMR data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Method of determining protein conformations by the two-dimensional nuclear Overhauser enhancement spectroscopy data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Structure and polymorphism of HIV-1 third variable loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Monte Carlo-minimization approach to the multiple-minima problem in protein folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Backbone-dependent rotamer library for proteins. Application to side-chain prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

AMBER: Assisted model building with energy refinement. A general program for modeling molecules and their interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Analysis of main chain torsion angles in proteins: prediction of NMR coupling constants for native and random coil conformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Chain reversals in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Comparison of protein structures in solution using local conformations derived from NMR data: application to cytochrome c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Conformational analysis of protein structures derived from NMR data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Calculation of conformational ensembles from potentials of mean force. An approach to the knowledge-based prediction of local structures in globular proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Crystal structure of the principal neutralization site of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

The complete Consensus V3 loop peptide of the envelope protein gp120 of HIV-1 shows pronounced helical character in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

N-linked glycosylation in C2 region of HIV-1 envelope reduces sensitivity to neutralizing antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Molecular determinants of the V3 loop of human immunodeficiency virus type 1 glycoprotein gp120 responsible for controlling cell tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Sequential resonance assignments as a basis for determination of spatial protein structures by high resolution proton nuclear magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

Conformational Features of a Synthetic Cyclic Peptide Corresponding to the Complete V3 Loop of the ELI HIV-1 Strain in Water

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2007.10507149

10.1080/07391102.2007.10507149

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

17508782